BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2476601
,
ZBTB7A
,
Fatty acid metabolic process
,
Obesity
,
Neuron
,
Pharmacogenetics
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
TNFRSF4
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Plasma cell of spleen
Natural killer cell of peripheral blood
Heart
T Lymphocyte (CD4+) of peripheral blood
Pancreas
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Lyme disease
Brucellosis
Infection due to Mycobacterium tuberculosis
Placental insufficiency
Bacterial infection due to Bacillus
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
LY2109761
Poliovirus Vaccines
grass pollen extract, alum-adsorbed
Nitrazepam
clebopride
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
FGFR1
MIR125A
LCP2
ELF4
SATB1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Diverse Role of OX40 on T Cells as a Therapeutic Target for Skin Diseases.
OX40 and OX40L Interaction in Cancer.
Elevated expression of TNFRSF4 impacts immune cell infiltration and gene mutation in hepatocellular …
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunother…
IL-33-ILC2 axis promotes anti-tumor CD8+ T cell responses via OX40 signaling.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of Pembrolizumab (MK-3475) vs. Brentuximab Vedotin in Participants With Relapsed or Refractory…
A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Sele…
Study of MK-8353 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Malignanc…
A Study of mRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001)
Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologo…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ